Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Adalat
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Adalat LA 30mg tablets
0206020R0BBAHAN
|
Adalat | Nifedipine | Cardiovascular System | 6,218 |
|
Adalat retard 20mg tablets
0206020R0BBAFAR
|
Adalat | Nifedipine | Cardiovascular System | 516 |
|
Adalat LA 60mg tablets
0206020R0BBAIAP
|
Adalat | Nifedipine | Cardiovascular System | 209 |
|
Adalat retard 10mg tablets
0206020R0BBAGAE
|
Adalat | Nifedipine | Cardiovascular System | 106 |
|
Adalat LA 20mg tablets
0206020R0BBAJAR
|
Adalat | Nifedipine | Cardiovascular System | 93 |
|
Adalat 10mg capsules
0206020R0BBABAB
|
Adalat | Nifedipine | Cardiovascular System | 20 |
|
Adalat 5mg capsules
0206020R0BBAAAA
|
Adalat | Nifedipine | Cardiovascular System | 6 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.